Published in J Urol on April 01, 1999
Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium. Proc Natl Acad Sci U S A (2001) 1.43
SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms. J Biol Chem (2010) 1.29
Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer. Clin Cancer Res (2005) 0.93
Analytic Validation of RNA In Situ Hybridization (RISH) for AR and AR-V7 Expression in Human Prostate Cancer. Clin Cancer Res (2016) 0.79
Stromal Androgen Receptor in Prostate Cancer Development and Progression. Cancers (Basel) (2017) 0.75
Androgen Receptor Expression in Epithelial and Stromal Cells of Prostatic Carcinoma and Benign Prostatic Hyperplasia. Open Access Maced J Med Sci (2017) 0.75
Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst (2000) 6.77
A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology (2001) 5.16
Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int (2006) 4.59
Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer (1997) 3.85
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med (2011) 3.63
Comparison of self-reported and medical record health care utilization measures. J Clin Epidemiol (1996) 3.47
Accuracy of frozen-section diagnosis of mammographically directed breast biopsies. Results of 1,490 consecutive cases. Am J Surg Pathol (1995) 3.02
The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Am J Clin Pathol (1997) 2.98
Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects. Muscle Nerve (1997) 2.86
Software for optimal matching in observational studies. Epidemiology (1996) 2.84
Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res (1997) 2.80
Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA (1995) 2.70
A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics (1997) 2.65
Screening for lung cancer. A critique of the Mayo Lung Project. Cancer (1991) 2.47
Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases. Am J Surg Pathol (1997) 2.33
Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists. Hum Pathol (2001) 2.31
Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer (2000) 2.28
Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab (1988) 2.20
Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate (2000) 2.19
Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol (2001) 2.15
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer (1998) 2.15
Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases. J Urol (1998) 2.14
Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol (1997) 2.12
A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N Engl J Med (1994) 2.11
Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol (1994) 2.10
Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery (1992) 2.06
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology (1998) 2.04
Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc (1991) 2.04
Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J Urol (1996) 2.04
Overexpression of the EphA2 tyrosine kinase in prostate cancer. Prostate (1999) 2.02
Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol (1986) 2.01
Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms. Mod Pathol (2001) 1.92
Artificial neural networks improve the accuracy of cancer survival prediction. Cancer (1997) 1.91
PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clin Proc (2001) 1.91
Locally invasive papillary thyroid carcinoma: 1940-1990. Head Neck (1994) 1.89
Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol (2000) 1.89
Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int (2006) 1.86
Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res (1995) 1.85
Accuracy of frozen section diagnosis in surgical pathology: review of a 1-year experience with 24,880 cases at Mayo Clinic Rochester. Mayo Clin Proc (1995) 1.84
Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer (1987) 1.79
Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res (1996) 1.78
Patterns of progression in prostate cancer. Lancet (1986) 1.78
Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. J Clin Oncol (1994) 1.75
Prognosis of patients with unilateral renal agenesis. Pediatr Nephrol (1992) 1.74
The periurethral glands do not significantly influence the serum prostate specific antigen concentration. J Urol (1996) 1.73
Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol (1994) 1.73
Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol (2001) 1.72
Pediatric reference intervals for 19 biologic variables in healthy children. Mayo Clin Proc (1990) 1.71
Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab (1995) 1.71
Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. J Natl Cancer Inst (1999) 1.70
Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum prostate-specific antigen concentration. Urology (1993) 1.67
Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984. Neuroepidemiology (1991) 1.65
The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA (1996) 1.65
A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy. J Am Soc Nephrol (2001) 1.64
Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis (1998) 1.64
Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol (2001) 1.63
Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin. Urology (1997) 1.63
Prostatic adenocarcinoma with glomeruloid features. Hum Pathol (1998) 1.63
Expression of early growth response genes in human prostate cancer. Cancer Res (1998) 1.62
Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen. Cancer (1998) 1.61
Renal oncocytoma: multifocality, bilateralism, metachronous tumor development and coexistent renal cell carcinoma. J Urol (1999) 1.61
Incidence rates of stroke in the eighties: the end of the decline in stroke? Stroke (1989) 1.59
Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: report of 30 cases. Hum Pathol (1994) 1.59
Papillary urothelial neoplasms of low malignant potential. Clinical and biologic implications. Cancer (1999) 1.59
Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer (2001) 1.58
Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res (1999) 1.58
The subsequent risk of internal cancer with Bowen's disease. A population-based study. JAMA (1991) 1.58
Villous adenoma of the urinary tract: a report of 23 cases, including 8 with coexistent adenocarcinoma. Am J Surg Pathol (1999) 1.58
Correlation of back extensor strength with thoracic kyphosis and lumbar lordosis in estrogen-deficient women. Am J Phys Med Rehabil (1996) 1.58
Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology (1998) 1.57
The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA (1993) 1.56
Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: A new proposal. Cancer (1999) 1.54
Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res (1995) 1.52
Comparison of renal ablation with cryotherapy, dry radiofrequency, and saline augmented radiofrequency in a porcine model. J Am Coll Surg (2001) 1.52
Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer. Urology (1993) 1.50
Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology (1997) 1.50
Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology (1997) 1.46
Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis. Am J Surg Pathol (1997) 1.46
Chondrosarcoma of the chest wall: factors affecting survival. Ann Thorac Surg (1985) 1.45
Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice. Mayo Clin Proc (1998) 1.42
Malignant lymphoma of the bladder: evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphoma. Am J Surg Pathol (1997) 1.42
Screening digital rectal examination and prostate cancer mortality: a population-based case-control study. Urology (1998) 1.41
Loss of heterozygosity on chromosome 13 is associated with advanced stage prostate cancer. J Urol (1999) 1.41